Peer Grande

Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Acute Coronary Care in the Elderly, Part I

New insights into the pathophysiology of dyslipidemia in type 2 diabetes

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study

The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction

Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

Universal Definition of Myocardial Infarction

Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes

Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

The Failing Heart — An Engine Out of Fuel

Prospects for Cardiovascular Research

Induction of Cardiac Fibrosis by Transforming Growth Factor-β1

Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies

C-Reactive Protein Levels and Outcomes after Statin Therapy

Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients

Utility of routine exercise treadmill testing early after percutaneous coronary intervention

Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

The Prognostic Value of Serum Troponin T in Unstable Angina

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

The changing landscape of atherosclerosis

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

The Pathogenesis of Rheumatoid Arthritis

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

Does the rest electrocardiogram after myocardial infarction determine the predictive value of exercise-induced st depression? A 2 year follow-up study in a veteran population

Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?

International differences in in-hospital revascularization and outcomes following acute myocardial infarction A multilevel analysis of patients in ASSENT-2

Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty

Triglycerides and cardiovascular disease

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Triglycerides on the rise: should we swap seats on the seesaw?

Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators

Women with acute coronary syndrome are less invasively examined and subsequently less treated than men

Ticagrelor

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

Prognostic value of the admission electrocardiogram in patients with unstable angina/non–ST-segment elevation myocardial infarction treated with very early revascularization

Avoiding bias from weak instruments in Mendelian randomization studies

Myocardial Markers of Injury:Evolution and Insights

Differential Mobilization of Subsets of Progenitor Cells from the Bone Marrow

Benefit of Early Invasive Therapy in Acute Coronary Syndromes

A Test in Context

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Guidelines for Percutaneous Coronary Interventions

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis

Myocardial Reperfusion Injury

Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era

How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?

Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: A pilot study

Third Universal Definition of Myocardial Infarction

Factors associated with failure to identify the culprit artery by the electrocardiogram in inferior ST-elevation myocardial infarction

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease

Does reperfusion injury exist in humans?

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Inflammation, Atherosclerosis, and Coronary Artery Disease

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

Mortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's Age

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial

System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions

Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

Integrins

Coronary-Artery Stents

Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction

Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction

C-Reactive Protein Is a Determinant of First-Ever Stroke: Prospective Nested Case-Referent Study

Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study

Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes

JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Rural Interhospital Transfer of ST-Elevation Myocardial Infarction Patients for Percutaneous Coronary Revascularization

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial

High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk

ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies

Hypertriglyceridemia in the Genomic Era: A New Paradigm

UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION

Elevated Troponin T Levels and Lesion Characteristics in Non–ST-Elevation Acute Coronary Syndromes

The Creatine Kinase System in Normal and Diseased Human Myocardium

Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene

Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure

Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy

Ability of Serum to Decrease Cellular AcylCoA:Cholesterol Acyl Transferase Activity Predicts Cardiovascular Outcomes

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population

Potential risks of bone marrow cell transplantation into infarcted hearts

Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction

National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases

Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction

Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy

RAPID EVALUATION OF CREATININE CLEARANCE

Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Collagen Scar Formation After Acute Myocardial Infarction

Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis

Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief

Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes

Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

Cardiogenic Shock in Patients With Acute Ischemic Syndromes With and Without ST-Segment Elevation

A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease

C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease

Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Genetic Loci Influencing C-reactive Protein Levels and Risk of Coronary Heart Disease

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

Growth Factors, Matrices, and Forces Combine and Control Stem Cells

Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

Platelet Glycoprotein IIb-IIIa Antagonists as Prototypical Integrin Blockers:  Novel Parenteral and Potential Oral Antithrombotic Agents

Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology

Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives

Increased Serum Concentrations of Procollagen Peptides in Essential Hypertension

Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief

Genetic insights into cardiometabolic risk factors.

Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel Disease

Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction

Admission standard electrocardiogram for early risk stratification in patients with unstable coronary artery disease not eligible for acute revascularization therapy: A TRIM substudy

Clinical significance of abnormal T waves in patients with non–ST-segment elevation acute coronary syndromes

Revascularization Compared to Medical Treatment in Patients with Silent vs. Symptomatic Residual Ischemia after Thrombolyzed Myocardial Infarction – The DANAMI Study

Genetically Elevated Apolipoprotein A-I, High-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

PCSK9R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease

Use of Biochemical Markers of Infarction for Diagnosing Perioperative Myocardial Infarction and Early Graft Occlusion After Coronary Artery Bypass Surgery

Release patterns of pregnancy‐associated plasma protein A in patients with acute coronary syndromes assessed by an optimized monoclonal antibody assay

“Mirror-lake” serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction

A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment

Coronary angiographic findings and troponin t in patients with unstable angina pectoris

Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia

Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease

Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the danish trial in acute myocardial infarction-2 (DANAMI-2)

Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction

The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)

High density lipoprotein cholesterol and arteriography in intermittent claudication

Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study

Comparison of ASTK, CK, CK-MB, and LD for the estimation of acute myocardial infarct size in man

[Enzyme diagnosis of acute myocardial infarction].

Diagnostic and prognostic implications of transient isolated negative T waves in suspected acute myocardial infarction

High-density lipoprotein cholesterol assay by magnesium dextransulphate precipitation

Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

The Prognostic Value of Predischarge Exercise Testing After Myocardial Infarction Treated With Either Primary PCI or Fibrinolysis: A DANAMI-2 Sub-Study

Estimation of acute myocardial infarct size in man by serum CK-MB measurements.

Diagnostic and prognostic significance of minimally elevated creatine kinase-mb in suspected acute myocardial infarction

Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI)

TRIB1 and GCKR Polymorphisms, Lipid Levels, and Risk of Ischemic Heart Disease in the General Population

Very Early Risk Stratification Using Combined ECG and Biochemical Assessment in Patients With Unstable Coronary Artery Disease (A Thrombin Inhibition in Myocardial Ischemia [TRIM] Substudy)

A comprehensive estimation of acute myocardial infarct size using enzymatic, electrocardiographic and mechanical methods

Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction.

Acute myocardial infarct size estimated by serum CK-MB determinations: Clinical accuracy and prognostic relevance utilizing a practical modification of the isoenzyme approach

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction

Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependent